Stock RN3N ARENA PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Financials Arena Pharmaceuticals BOERSE MUENCHEN

Equities

RN3N

US0400476075

Real-time BOERSE MUENCHEN
Other stock markets
 		5-day change 1st Jan Change
- EUR -.--% Intraday chart for Arena Pharmaceuticals +6.47% +10.37%
2022 Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement CI
2022 Arena Pharmaceuticals, Inc.(NasdaqGS:ARNA) dropped from S&P Biotechnology Select Industry Index CI

Income Statement Evolution (Annual data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period:
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. ARNA Stock
  4. RN3N Stock
  5. Financials Arena Pharmaceuticals